Evidence map›Paper›PMID 34826061›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2021

The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings.

Jean M Bidlack, Sulie L Chang, Sylvia Fitting, Howard E Gendelman, Santhi Gorantla, Santosh Kumar, Maria Cecilia Garibaldi Marcondes, Douglas D Meigs, Loyda M Melendez, Ilker K Sariyer and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Neuroimmune Pharmacology of SARS-CoV-2.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jean M BidlackDepartment of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.
Sulie L ChangDepartment of Biological Sciences, Institute of Neuroimmune Pharmacology, Seton Hall University, South Orange, NJ, USA.
Sylvia FittingDepartment of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Howard E GendelmanDepartment of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Santhi GorantlaDepartment of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Santosh KumarDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Maria Cecilia Garibaldi MarcondesSan Diego Biomedical Research Institute (Neuroimmunology Program), CA, San Diego, USA.
Douglas D MeigsDepartment of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA. doug.meigs@unmc.edu.ORCID 0000-0002-7540-614X
Loyda M MelendezDepartment of Microbiology and Medical Zoology, University of Puerto Rico-Medical Sciences Campus, San Juan, Puerto Rico, USA.
Ilker K SariyerDepartment of Neuroscience and Center for Neurovirology, Lewis Katz School of Medicine, Temple University, PA, Philadelphia, USA.
Sowmya YelamanchiliDepartment of Anesthesiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

Funding

Targeted lipid nanoparticles for gene therapeutics delivery approach to eradicating HIV reservoirsR01MH121402 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Benson Edagwa, Howard E Gendelman · 2019 to 2026
$4.9M
Dopamine system as reporter of HIV status and inflammation in Meth abusersR01DA047822 · NIDA · SAN DIEGO BIOMEDICAL RESEARCH INSTITUTE · PI MARCONDES, MARIA CECILIA GARIBALDI · 2019 to 2023
$2.2M
Immunomodulation of nicotine in HIV-1Tg rat brainR01DA046258 · NIDA · SETON HALL UNIVERSITY · PI CHANG, SULIE L. · 2018 to 2022
$1.7M
Monocytic and exosomal cytochrome P450s in smoking-mediated HIV-1 pathogenesisR01DA047178 · NIDA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CORY, THEODORE, KUMAR, SANTOSH · 2018 to 2022
$1.7M
Extracellular vesicles-based drug delivery of antiretroviral regimen to target CNS HIV reservoirsR21MH125670 · NIMH · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KUMAR, SANTOSH · 2021 to 2022
$424k
NIDA NIH HHS DA046258NIDA NIH HHS DA047178NIDA NIH HHS R01 DA046258NIDA NIH HHS R01 DA047178NIDA NIH HHS R01 DA047822NIMH NIH HHS R01 MH121402NIMH NIH HHS R21 MH125670
6 · The paper itself

Abstract

In spring of 2021, the Society on NeuroImmune Pharmacology (SNIP) organized a virtual workshop on the coronavirus disease 2019 (COVID-19). The daylong event's fourth and final symposium, "Well-being and reflections," offered a glimpse at the pandemic's impact on the lives of our scientists and educators. This manuscript includes a brief summary of the symposium, a transcription of our incoming president Dr. Santosh Kumar's lecture, titled "Intervention and improved well-being of basic science researchers during the COVID-19 era: a case study," and the panel discussion that followed, "Reflection and sharing," featuring Drs. Jean M. Bidlack, Sylvia Fitting, Santhi Gorantla, Maria Cecilia G. Marcondes, Loyda M. Melendez, and Ilker K. Sariyer. The conclusion of this manuscript includes comments from SNIP's president Dr. Sulie L. Chang and our Chief Editor, Dr. Howard E. Gendelman. Drs. Sowmya Yelamanchili and Jeymohan Joseph co-chaired the symposium.

Indexed as

COVID-19HumansPandemicsSARS-CoV-2COVID-19Diversity, equity, and inclusionEarly-career investigatorsNeuroimmune pharmacologyOral historySARS-CoV-2TherapeuticsVaccinesWell-being

Identifiers

PMID34826061
PMCPMC8616745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.